Skip to main content
Top
Published in: Lung 2/2016

01-04-2016

Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?

Authors: Eulogio Pleguezuelos, Cristina Esquinas, Eva Moreno, Lluis Guirao, Javier Ortiz, Joan Garcia-Alsina, Alex Merí, Marc Miravitlles

Published in: Lung | Issue 2/2016

Login to get access

Abstract

Background

Muscular dysfunction has been described as one of the systemic manifestations of chronic obstructive pulmonary disease (COPD).

Objective

The aim of this study was to evaluate muscular strength of the different anatomical compartments in patients with severe COPD compared with healthy controls.

Method

We performed a cross-sectional study in patients with severe COPD. We evaluated the muscular strength of the respiratory muscles, flexors and extensors of the cervical spine and knee, as well as handgrip force. The 6-min walking test (6MWT) and serum inflammatory markers were also analysed.

Results

Twenty-eight male patients with COPD (mean age 67.8 years, mean FEV1 (%) 39 %) and 24 male healthy controls (mean age 70.2 years) were studied. The strength of the flexors and extensors of the knee was significantly reduced in patients with COPD (p < 0.001 and p = 0.003). No differences were observed in the flexors and extensors of the cervical spine and handgrip force between groups. No correlation was observed between the muscular strength in the different anatomic compartments and the concentrations of blood inflammatory biomarkers or the metres walked in the 6MWT in COPD patients. However, a significant negative linear correlation was observed between the 6MWT and IL-6 and IL-8 levels (rho = −0.67, p = 0.001; rho = −0.57, p = 0.008). In addition, we found a negative correlation between the 6MWT and inspiratory capacity (rho = −0.755, p = 0.031).

Conclusions

Our results suggest that muscular dysfunction in patients with COPD differs in different muscular compartments. The main factor for a reduced exercise capacity was a reduction in inspiratory capacity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Watz H, Waschki B, Boehme C et al (2007) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity. Am J Respir Crit Care Med 29:653–659 Watz H, Waschki B, Boehme C et al (2007) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity. Am J Respir Crit Care Med 29:653–659
2.
go back to reference Gea J, Casadevall C, Pascual S et al (2012) Respiratory diseases and muscle dysfunction. Expert Rev Respir Med 6:75–90CrossRefPubMed Gea J, Casadevall C, Pascual S et al (2012) Respiratory diseases and muscle dysfunction. Expert Rev Respir Med 6:75–90CrossRefPubMed
3.
go back to reference Hopkinson NS, Tennant RC, Dayer MJ et al (2007) A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 13:8–25 Hopkinson NS, Tennant RC, Dayer MJ et al (2007) A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 13:8–25
4.
go back to reference Gea J, Orozco-Levi M, Barreiro E, Ferrer A et al (2001) Structural and functional changes in the skeletal muscles of COPD patients: the “compartments” theory. Monaldi Arch Chest Dis 56:214–224PubMed Gea J, Orozco-Levi M, Barreiro E, Ferrer A et al (2001) Structural and functional changes in the skeletal muscles of COPD patients: the “compartments” theory. Monaldi Arch Chest Dis 56:214–224PubMed
5.
go back to reference Swallow EB, Reyes D, Hopkinson NS et al (2007) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62:115–120CrossRefPubMedPubMedCentral Swallow EB, Reyes D, Hopkinson NS et al (2007) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62:115–120CrossRefPubMedPubMedCentral
6.
go back to reference Takeda K, Kawasaki Y, Yoshida K et al (2013) The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 8:347–351CrossRefPubMedPubMedCentral Takeda K, Kawasaki Y, Yoshida K et al (2013) The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 8:347–351CrossRefPubMedPubMedCentral
7.
go back to reference Seger JY, Westing SH, Hanson M et al (1988) A new dynamometer measuring concentric and eccentric muscle strength in accelerated, decelerated, or isokinetic movements. Validity and reproducibility. Eur J Appl Physiol Occup Physiol 57:526–533CrossRefPubMed Seger JY, Westing SH, Hanson M et al (1988) A new dynamometer measuring concentric and eccentric muscle strength in accelerated, decelerated, or isokinetic movements. Validity and reproducibility. Eur J Appl Physiol Occup Physiol 57:526–533CrossRefPubMed
8.
go back to reference Ritti-Dias RM, Basyches M, Câmara L et al (2010) Test-retest reliability of isokinetic strength and endurance tests in patients with intermittent claudication. Vasc Med 15:275–278CrossRefPubMed Ritti-Dias RM, Basyches M, Câmara L et al (2010) Test-retest reliability of isokinetic strength and endurance tests in patients with intermittent claudication. Vasc Med 15:275–278CrossRefPubMed
9.
go back to reference Pleguezuelos E, Pérez ME, Guirao L et al (2013) Effects of whole body vibration training in patients with severe chronic obstructive pulmonary disease. Respirology 18:1028–1034CrossRefPubMed Pleguezuelos E, Pérez ME, Guirao L et al (2013) Effects of whole body vibration training in patients with severe chronic obstructive pulmonary disease. Respirology 18:1028–1034CrossRefPubMed
10.
go back to reference Chiu TT, Lam TH, Hedley AJ (2002) Maximal isometric muscle strength of the cervical spine in healthy volunteers. Clin Rehabil 16:772–779CrossRefPubMed Chiu TT, Lam TH, Hedley AJ (2002) Maximal isometric muscle strength of the cervical spine in healthy volunteers. Clin Rehabil 16:772–779CrossRefPubMed
11.
go back to reference Peolsson A, Hedlund R, Oberg B (2001) Intra- and inter-tester reliability and reference values for hand strength. J Rehabil Med 33:36–41CrossRefPubMed Peolsson A, Hedlund R, Oberg B (2001) Intra- and inter-tester reliability and reference values for hand strength. J Rehabil Med 33:36–41CrossRefPubMed
12.
go back to reference American Thoracic Society ATS Statement (2002) Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef American Thoracic Society ATS Statement (2002) Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef
14.
go back to reference Agustí A, Edwards LD, Rennard SI et al (2012) Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7:e374–e383CrossRef Agustí A, Edwards LD, Rennard SI et al (2012) Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7:e374–e383CrossRef
15.
go back to reference Evans RA, Kaplovitch E, Beauchamp MK et al (2015) Is quadriceps endurance reduced in COPD? A systematic review. Chest 147:673–684CrossRefPubMed Evans RA, Kaplovitch E, Beauchamp MK et al (2015) Is quadriceps endurance reduced in COPD? A systematic review. Chest 147:673–684CrossRefPubMed
16.
go back to reference Pitta F, Troosters T, Spruit MA et al (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:972–977CrossRefPubMed Pitta F, Troosters T, Spruit MA et al (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:972–977CrossRefPubMed
17.
go back to reference Hunt T, Madigan S, Williams MT et al (2014) Use of time in people with chronic obstructive pulmonary disease—a systematic review. Int J Chron Obstruct Pulmon Dis 12:1377–1388CrossRef Hunt T, Madigan S, Williams MT et al (2014) Use of time in people with chronic obstructive pulmonary disease—a systematic review. Int J Chron Obstruct Pulmon Dis 12:1377–1388CrossRef
18.
go back to reference Spector SA, Simard CP, Fournier M et al (1982) Architectural alterations of rat hind-limb skeletal muscles immobilized at different lengths. Exp Neurol 76:94–110CrossRefPubMed Spector SA, Simard CP, Fournier M et al (1982) Architectural alterations of rat hind-limb skeletal muscles immobilized at different lengths. Exp Neurol 76:94–110CrossRefPubMed
19.
go back to reference Williams PE (1998) Effect of intermittent stretch on immobilised muscle. Ann Rheum Dis 47:1014–1016CrossRef Williams PE (1998) Effect of intermittent stretch on immobilised muscle. Ann Rheum Dis 47:1014–1016CrossRef
20.
go back to reference Coutinho EL, Gomes ARS, França CN et al (2004) Effect of passive stretching on the immobilized soleus muscle fibre morphology. Braz J Med Biol Res 37:1853–1861CrossRefPubMed Coutinho EL, Gomes ARS, França CN et al (2004) Effect of passive stretching on the immobilized soleus muscle fibre morphology. Braz J Med Biol Res 37:1853–1861CrossRefPubMed
21.
go back to reference Boyle R, Pompeiano O (1980) Responses of vestibulospinal neuronsto sinusoidal rotation of neck. J Neurophysiol 44:633–649PubMed Boyle R, Pompeiano O (1980) Responses of vestibulospinal neuronsto sinusoidal rotation of neck. J Neurophysiol 44:633–649PubMed
22.
go back to reference Heijdra YF, Pinto-Plata V, Frants R et al (2003) Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 124:75–82CrossRefPubMed Heijdra YF, Pinto-Plata V, Frants R et al (2003) Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 124:75–82CrossRefPubMed
23.
go back to reference Gosselink R, Troosters T, Decramer M (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976–980CrossRefPubMed Gosselink R, Troosters T, Decramer M (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976–980CrossRefPubMed
24.
go back to reference Shah S, Nahar P, Vaidya S et al (2013) Upper limb muscle strength and endurance in chronic obstructive pulmonary disease. Indian J Med Res 138:492–496PubMedPubMedCentral Shah S, Nahar P, Vaidya S et al (2013) Upper limb muscle strength and endurance in chronic obstructive pulmonary disease. Indian J Med Res 138:492–496PubMedPubMedCentral
25.
go back to reference García-Río F, Miravitlles M, Soriano JB et al (2010) Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 11:63CrossRefPubMedPubMedCentral García-Río F, Miravitlles M, Soriano JB et al (2010) Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 11:63CrossRefPubMedPubMedCentral
26.
go back to reference Yende S, Waterer GW, Tolley EA et al (2006) Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well-functioning elderly subjects. Thorax 61:10–16CrossRefPubMedPubMedCentral Yende S, Waterer GW, Tolley EA et al (2006) Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well-functioning elderly subjects. Thorax 61:10–16CrossRefPubMedPubMedCentral
27.
go back to reference Gagnon P, Lemire BB, Dubé A et al (2014) Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD. Respir Res 15:4CrossRefPubMedPubMedCentral Gagnon P, Lemire BB, Dubé A et al (2014) Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD. Respir Res 15:4CrossRefPubMedPubMedCentral
28.
go back to reference Barreiro E, Schols AM, Polkey MI et al (2008) ENIGMA in COPD project. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63:100–107CrossRefPubMed Barreiro E, Schols AM, Polkey MI et al (2008) ENIGMA in COPD project. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63:100–107CrossRefPubMed
29.
go back to reference Gan WQ, Man SF, Senthilselvan A et al (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580CrossRefPubMedPubMedCentral Gan WQ, Man SF, Senthilselvan A et al (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580CrossRefPubMedPubMedCentral
30.
go back to reference Stockley RA (2009) Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Curr Med Res Opin 25:1235–1245CrossRefPubMed Stockley RA (2009) Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Curr Med Res Opin 25:1235–1245CrossRefPubMed
31.
go back to reference Gatta D, Aliprandi G, Pini L et al (2011) Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. Eur Rev Med Pharmacol Sci 15:1068–1073PubMed Gatta D, Aliprandi G, Pini L et al (2011) Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. Eur Rev Med Pharmacol Sci 15:1068–1073PubMed
32.
go back to reference Garcia-Rio F, Lores V, Mediano O et al (2009) Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 180:506–512CrossRefPubMed Garcia-Rio F, Lores V, Mediano O et al (2009) Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 180:506–512CrossRefPubMed
33.
go back to reference Rossi A, Aisanov ZR, Avdeev S et al (2015) Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 109:785–802CrossRefPubMed Rossi A, Aisanov ZR, Avdeev S et al (2015) Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 109:785–802CrossRefPubMed
34.
go back to reference Miravitlles M, Soriano JB, García-Río F et al (2009) Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863–868CrossRefPubMed Miravitlles M, Soriano JB, García-Río F et al (2009) Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863–868CrossRefPubMed
Metadata
Title
Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?
Authors
Eulogio Pleguezuelos
Cristina Esquinas
Eva Moreno
Lluis Guirao
Javier Ortiz
Joan Garcia-Alsina
Alex Merí
Marc Miravitlles
Publication date
01-04-2016
Publisher
Springer US
Published in
Lung / Issue 2/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-015-9838-z

Other articles of this Issue 2/2016

Lung 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.